V003-2239 Screening compound: N-[(furan-2-yl)methyl]-N-(2-{4-[6-(4-methylphenyl)pyridazin-3-yl]piperazin-1-yl}-2-oxoethyl)benzamide

V003-2239 Screening compound: N-[(furan-2-yl)methyl]-N-(2-{4-[6-(4-methylphenyl)pyridazin-3-yl]piperazin-1-yl}-2-oxoethyl)benzamide
V003-2239 Screening compound: N-[(furan-2-yl)methyl]-N-(2-{4-[6-(4-methylphenyl)pyridazin-3-yl]piperazin-1-yl}-2-oxoethyl)benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V003-2239
N-[(furan-2-yl)methyl]-N-(2-{4-[6-(4-methylphenyl)pyridazin-3-yl]piperazin-1-yl}-2-oxoethyl)benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V003-2239

Molecular Formula

C29H29N5O3 (C29 H29 N5 O3)

Compound Name

N-[(furan-2-yl)methyl]-N-(2-{4-[6-(4-methylphenyl)pyridazin-3-yl]piperazin-1-yl}-2-oxoethyl)benzamide

IUPAC name

N-[(furan-2-yl)methyl]-N-(2-{4-[6-(4-methylphenyl)pyridazin-3-yl]piperazin-1-yl}-2-oxoethyl)benzamide

SMILES

Cc(cc1)ccc1-c(cc1)nnc1N(CC1)CCN1C(CN(Cc1ccco1)C(c1ccccc1)=O)=O

InChI

InChI=1S/C29H29N5O3/c1-22-9-11-23(12-10-22)26-13-14-27(31-30-26)32-15-17-33(18-16-32)28(35)21-34(20-25-8-5-19-37-25)29(36)24-6-3-2-4-7-24/h2-14,19H,15-18,20-21H2,1H3

InChI Key

OJTUKDCGWPSITP-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19832340

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

495.58

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.905

Distribution Coefficient, logD

3.884

Water Solubility, LogSw

-3.86

Polar Surface Area

64.514

Acid Dissociation Constant (pKa)

22.66

Base Dissociation Constant (pKb)

6.09

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

24.10

V003-2239 in Drug Discovery

Included in Screening Libraries

CNS Targets (44014 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system

References: we are preparing a list of scientific research reports with V003-2239 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V003-2239?
Check Price and Availability of V003-2239, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V003-2239 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V003-2239
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V003-2239
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V003-2239 available by request